Alu-polymerase chain reaction genomic fingerprinting technique identifies multiple genetic loci associated with pancreatic tumourigenesis

Genes Chromosomes and Cancer

Volumn 18, Issue 1, 1997, Pages 30-41

  McKie, Arthur B ^a   Iwamura, Takeshi ^b   Leung, Hing Y ^a   Hollingsworth, Michael A ^b   Lemoine, Nicholas R ^a,c  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALU SEQUENCE; ARTICLE; CARCINOGENESIS; CYTOGENETICS; DISEASE ASSOCIATION; DNA FINGERPRINTING; GENE ACTIVATION; GENE LOCUS; GENE REARRANGEMENT; GENOME IMPRINTING; HUMAN; HUMAN TISSUE; PANCREAS CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DOMAIN;

BLOTTING, SOUTHERN; DNA FINGERPRINTING; DNA PRIMERS; DNA, NEOPLASM; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GENE REARRANGEMENT; HUMANS; IN SITU HYBRIDIZATION; PANCREATIC NEOPLASMS; POLYMERASE CHAIN REACTION; REPETITIVE SEQUENCES, NUCLEIC ACID; TUMOR CELLS, CULTURED;

EID: 0031015313     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199701)18:1<30::AID-GCC4>3.0.CO;2-2     Document Type: Article

References (46)

1. Almoguera C, Shibata, D, Forrester R, Martin J, Perucho M (1988) Most human carcinomas of exocrine pancreas contain mutant c-K-ras genes. Cell 53:549-554.
2. Bardi G, Johansson B, Pandis N, Mandahl N, Bak JE, Andren SA, Mitelman F, Heim S (1993) Karyotypic abnormalities in tumours of the pancreas. Br J Cancer 67:1106-1112.
3. Barton CM, Staddon SL, Hughes CM, Hall PA, O'Sullivan C, Kloppel G, Theis B, Russell RC, Neoptolemos JP, Williamson RCN, Lane DP, Lemoine NR (1991) Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer Br J Cancer 64:1076-1082.
4. Bartsch D, Shevlin DW, Tung WS, Kisker O, Wells SA, Goodfellow PJ (1995) Frequent mutations of CDKN2 in pri mary pancreatic adenocarcinomas. Genes Chromosom Cancer 14:189-195.
5. Caldas C, Mahn SA, da Costa LT, Redston MS, Schutte M, Seymour AB, Weinstein CL, Hruban RH, Yeo CJ, Kern SE (1994a) Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nature Genet 8: 27-31.
6. Caldas C, Hahn SA, Hruban RH, Redston MS, Yeo CJ, Kern SE (1994b) Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia. Cancer Res 54:3568-3573.
7. Chissoe SL, Bodenteich A, Wang YF, Wang YP, Burian D, Clifton SW, Crabtree J, Freeman A, Iyer K, Li JA, Ma YC, McLaury HJ, Pan HQ, Sarhan OH, Toth S, Wang ZL, Zhang GZ, Heisterkamp N, Groffen J, Roe BA (1995) Sequence and analysis of the human abl gene, the bcr gene, and regions involved in the Philadelphia chromosomal translocation. Genomics 27:67-82.
8. Daniels GR, Fox GM, Loewensteiner D, Schmid CW, Deininger PL (1983) Species-specific homogeneity of primate Alu family of repeated sequences. Nucleic Acids Res 11:7579-7593.
9. DiGiuseppe JA, Hruban RH, Offerhaus GJA, Clement MJ, van den Berg FM, Cameron JL, van Mansfeld ADM (1994) Detection of K-ras mutations in mucinous pancreatic duct hyperplasia from a patient with a family history of pancreatic cancer. Am J Pathol 144:889-895.
10. Feinberg AP, Vogelstein B (1984) A technique for radiolabelling DNA restriction eudonuclease fragments to high specific activity. Anal Biochem 137:266-267.
11. Gress TM, Muller-Pillasch F, Adler G, Lehrach H (1994) European Pancreatic Cancer Reference Library System (EPCRLS). Eur J Cancer 30A:1391-1394.
12. Griffin CA, Hruban RH, Morsberger LA, Ellingham T, Long PP, Jaffee EM, Hauda KM, Bohlander SK, Yeo CJ (1995) Consistent chromosome abnormalities in adenocarcinoma of the pancreas, Cancer Res 55:2394-2399.
13. Guronova L, Johansson B, Dawiskiba S, Andren-Sandberg A, Jin YS, Mandahl N, Heim S, Mitelman F (1995) Massive cytogenetic heterogeneity in a pancreatic carcinoma - Fifty-four karyotypically unrelated clones. Genes Chromosom Cancer 14:259-266.
14. Hahn SA, Seymour AB, Hoque S, Schutte M, da Costa LT, Redston MS, Caldas C, Weinstein CL, Fischer A, Yeo CJ, Hruban RH, Kern SE (1995) Allelotype of pancreatic cancer using xenograft enrichment. Cancer Res 55:4670-4675.
15. Hahn SA, Schutte M, Hoque ATMS, Moskaluk CA, Dacosta LT, Rozenblum E, Weinstein CL, Fischer A, Yeo CJ, Hruban RH, Kern SE (1996) DPC4, a candidate tumor-suppressor gene at human-chromosome 18q21.1. Science 271:350-353.
16. Holton TA, Graham MW (1990) A simple and efficient method for direct cloning of PCR products using ddT-tailed vectors, Nucleic Acids Res 19:1156.
17. Ionov Y, Peinado MA, Malkhosyan S, Shibata D, Perucho M (1993) Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colorectal carcinogenesis. Nature 363:558-561.
18. Iwamura T, Katsuki, T, Ide K (1987) Establishment and characterization of a human pancreatic cancer cell line (SUIT-2) producing carcinoembryonic antigen and carbohydrate antigen 19-9. Jpn J Cancer Res 78:54-62.
19. Johansson B, Bardi G, Pandis N, Guronova L, Backman PL, Mandahl N, Dawiskiba, S, Andren-Sandberg A, Heim S, Mitelman F (1994) Karyotypic pattern of pancreatic adenocarcinomas correlates with survival and tumor grade. Int J Cancer 58:8-13.
20. Jurka J (1989) Novel families of interspersed repetitive elements from the human genome. Nucleic Acids Res 18:137-141.
21. Kalthoff H, Schmiegel W, Roeder C, Kasche D, Schmidt A, Lauer G, Thiele HG, Honold G, Pantel K, Riethmuller G, Scherer E, Maurer J, Maacke H, Deppert W (1993) p53 and K-ras alterations in pancreatic epithelial cell lesions. Oncogene 8:289-298.
22. Lehrach H, Drmanac R, Hoheisel J, Larin Z, Lennon G, Monaco AP, Nizetic D, Zehetner G, Poustka A-M (1990) Hybridisation finger-printing in genome mapping and sequencing. In Davies KE, Tilghman SM (eds): Genome Analysis, Vol 1: Genetic and Physical Mapping. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, pp 39-81.
23. Lemoine NR, Jain S, Hughes CM, Staddon SL, Mailler B, Hall PA, Kloppel G (1992) Ki-ras oncogene activation in preinvasive pancreatic cancer. Gastroenterology 102:230-236.
24. Lemoine NR, Hall PA, Motojima K, Urano T, Nagata Y, Shiku H, Tsunoda T, Kanewatsu T, Searpa A, Zamboni G, Hirohashi S (1993) Molecular biology of pancreatic cancer. In Pour PM (ed): Atlas for International Classification of Pancreatic Tumors. Amsterdam: Elsevier, pp 257-264.
25. Lisitsyn N, Lisitsyn N, Wigler M (1993) Cloning the differences between two complex genomes. Science 259:946-951.
26. Liu Q, Yan Y-X, McClure M, Nakagawa H, Fujimura F, Rustgi AK (1995) MTS-1 (CDKN2) tumor suppressor gene deletions are a frequent event in esophagus squamous cancer and pancreatic adenocarcinoma cell lines. Oncogene 10:619-622.
27. McKie AB, Filipe MI, Lemoine NR (1993) Abnormalities affecting the APC and MCC tumour suppressor gene loci on chromosome 5q occur frequently in gastric cancer but not in pancreatic cancer. Int J Cancer 55:598-603.
28. Moyzis, RK, Torney DC, Meyne J, Buckingham JM, Wu JR, Burks C, Sirotkin KM, Goad WB (1989) The distribution of interspersed repetitive DNA sequences in the human genome. Genomics 4:273-289.
29. Nelson DL, Ledbetter SA, Corbo L, Victoria MF, Ramirez-Solis R, Webster TD, Ledbetter DH, Caskey CT (1989) Alu-polymerase chain reaction: A method for the rapid isolation of human specific sequences from complex DNA sources. Proc Natl Acad Sci USA 86:6686-6690.
30. Niederhuber JE, Brennan MF, Menck HR (1995) The National Cancer Database report on pancreatic cancer. Cancer 76:1671-1677.
31. Nyström-Lahti M, Kristo P, Nicolaides NC, Clang SY, Aaltonen LA, Moisio AL, Järvinen HJ, Mecklin JP, Kinzler KW, Vogelstein B, de la Chapelle A, Peltomäki P (1995) Founding mutations and Alu-mediated recombination in hereditary colon cancer. Nature Med 1:1203-1206.
32. Peinado MA, Malkhossan S, Velazquez A, Perucho M (1992) Isolation and characterization of allelic losses and gains in colorectal tumors by arbitrarily primed polymerase chain reaction. Proc Natl Acad Sci USA 89:10065-10069.
33. Pierce JC, Sauer B, Sternberg N (1992) A positive selection vector for cloning high molecular weight DNA by the bacteriophage P1 system: Improved cloning efficiency. Proc Natl Acad Sci USA 89:2056-2060.
34. Redston MS, Caldas C, Seymour AB, Hruban RH, da Costa L, Yeo CJ, Kern SE (1994) p53 mutations in pancreatic carcinoma and evidence of common homocopolymer tracts in DNA microdeletions. Cancer Res 54:3025-3033.
35. Scarpa A, Capelli P, Mukai K, Zamboni G, Oda T, Iacono C, Hirohashi S (1993) Pancreatic adenocarcinomas frequently show p53 gene mutations. Am J Pathol 142:1534-1543.
36. Schmid (1982) The Alu family of dispersed repetitive elements. Science 216:1065-1070.
37. Schutte M, Kern SE (1995) The molecular genetics of pancreatic cancer. In Neoptolemos JP, Lemoinc NR (eds): Pancreatic Cancer: Molecular and Clinical Advances, Oxford: Blackwell Science, pp 115-132.
38. Schutte M, da Costa LT, Hahn SA, Moskaluk C, Hoque ATMS, Rozenblum E, Weinstein CL, Bittner M, Meltzer PS, Trent JM, Yeo CJ, Hruban RH, Kern SE (1995) Identification by representational difference analysis of a homozygous deletion in pancreatic carcinoma that lies within the BRCA2 region. Proc Natl Acad Sci USA 92:5950-5954.
39. Sealey PG, Whittaker PA, Southern EM (1985) Removal of repeated sequences from hybridisation probes. Nucleic acids Res 13:1905-1922.
40. Skowronski J, Fanning TG, Singer MF (1988) Unit-length line-1 transcripts in human teratocarcinoma cells. Mol Cell Biol 8:1385-1397.
41. Taniguchi S (1994) Heterogeneities of attachment, chemotaxis and protease production among clones with different metastatic potentials. Exp Metast 12:238-244.
42. Taniguchi S, Iwamura T, Katsuki T (1992) Correlation between spontaneous metastatic potential and type I collagenolytic activity in a human pancreatic cancer cell line (SUIT-2) and sublines. Clin Exp Metast 10:259-266.
43. Tycko B, Smith SD, Sklar J (1991) Chromosomal translocations joining LCK and TCRB loci in human T cell leukemia. J Exp Med 174:867-873.
44. Welsh J, McClelland M (1990) Fingerprinting genomes using PCR with arbitrary primers. Nucleic Acids Res 18:7213-7218.
45. Williams JG, Kubelik AR, Livak KJ, Rafalski JA, Tingey SV (1990) DNA polymorphisms amplified by arbitrary primers are useful as genetic markers. Nucleic Acids Res 18:6531-6535.
46. Yanagisawa A, Kato Y, Ohtake K, Kitagawa T, Ohashi K, Hori M, Takagi K, Sugano H (1991) c-Ki-ras point mutations in ductectatictype mucinous cystic neoplasms of the pancreas. Jpn J Cancer Res 82:1057-1060.